NetworkNewsWire Editorial Coverage
NEW YORK, July 15, 2025 /CNW/ -- For decades, mining has been defined by high-risk, high-capex exploration, where success hinges on one-in-a-thousand...
NetworkNewsWire Editorial Coverage
NEW YORK, July 15, 2025 /PRNewswire/ -- For decades, mining has been defined by high-risk, high-capex exploration, where success hinges on one-in-a-thousand...
NetworkNewsWire Editorial Coverage
NEW YORK, July 15, 2025 /PRNewswire/ -- For decades, mining has been defined by high-risk, high-capex exploration, where success hinges on one-in-a-thousand...
TSXV: ESBL
VANCOUVER, BC, July 15, 2025 /PRNewswire/ - Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company"), a developer of gluten-free and health-focused...
DALLAS, July 14, 2025 (GLOBE NEWSWIRE) -- The Andrew Hillman Scholarship for Entrepreneurs is now open for applications, offering undergraduate students across the United States a unique opportunity to gain recognition and financial support for their entrepreneurial aspirations. Created by renowned business strategist and investor Andrew Hillman, the scholarship seeks to identify and support students who demonstrate a clear vision, innovative mindset, and a deep interest in building and leading successful business ventures.
BEIJING, July 14, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China,...
TORONTO, July 14, 2025 /PRNewswire/ - Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) Power Metallic is pleased to...
HOUSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("Targa" or the "Company") announced today that its board of directors has declared a quarterly cash dividend of $1.00 per common share, or $4.00 per common share on an annualized basis, for the second quarter of 2025. This cash dividend will be paid August 15, 2025 on all outstanding common shares to holders of record as of the close of business on July 31, 2025.
SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the appointment of Marc. R Theoret, M.D. to assume the newly created position of Senior Vice President, Regulatory Strategy, where he will focus on clinical regulatory strategy for Iovance’s pipeline. Effective immediately, Dr. Theoret will report to Dr. Raj K. Puri, M.D., Ph.D., Chief Regulatory Officer.
CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Sandy Mahatme as Chief Financial Officer and Chief Business Officer, effective July 9, 2025.
"All In With AI: Actionable Strategies for Financial Advisors" Includes Webinars, Conference Sessions
DUBLIN, Ohio, July 10, 2025 /PRNewswire/ -- Meeder Advisory Services (Meeder) announced the...
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary – Cancer rates are...
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary – Cancer rates are...